세계의 액체생검 시장 : 바이오마커별(CTC, ct-DNA, 소포), 암 종류별, 제품별(검사 장비, 시약), 지역별, 국가별 - 기회와 예측
Global Liquid Biopsy Market: Analysis By Biomarkers (C-Tumor Cells, C-Tumor DNA, Vesicles), Cancer Type, By Product (Instruments, Reagents), By Region, By Country (2019 Edition): Opportunities and Forecast (2017-2024)
상품코드 : 915107
리서치사 : Azoth Analytics
발행일 : 2019년 10월
페이지 정보 : 영문 200 Pages
US $ 1,800 ₩ 2,126,000
PDF by E-mail (Single User License)
US $ 2,400 ₩ 2,835,000
PDF by E-mail (Enterprise License)


한글목차

세계의 액체생검(Liquid Biopsy) 시장에 대해 분석했으며, 제품 개요와 시장의 기본 구조, 관련 질환 개요, 주요 시장 성장 촉진·억제요인, 시장 규모 동향 전망(과거 5년간·향후 6년간), 바이오마커별·암 종류별·제품별 상세 동향, 지역별·주요 국가의 시장 구조와 동향, 주요 기업 개요와 시장 점유율 등을 조사했습니다.

제1장 분석 방법

제2장 주요 요약

제3장 전략 제안

제4장 액체생검 시장 : 제품 개요

제5장 세계의 액체생검 시장 : 성장률과 예측(통산 8년간)

제6장 세계의 액체생검 시장 : 분야별 분석

제7장 세계의 액체생검 시장 : 지역별 분석

제8장 세계의 액체생검 시장 : 경쟁 상황

제9장 세계의 액체생검 시장 : 시장 역학

제10장 Porter's Five Forces 분석

제11장 SWOT 분석

제12장 정책 및 규제 상황

제13장 기업 개요

KSM 19.11.20
영문 목차

영문목차

Executive Summary

According to Azoth Analytics research report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018.

Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita healthcare expenditure and rapid adoption of novel diagnostic test by oncologist. Further, rising awareness for the early detection of cancer and sharp rise in its incidences have contributed to the growth rate of Liquid Biopsy Market.

Among the Circulating Biomarker, Ct- DNA is the most used biomarker for the diagnosis in pre and post cancerous stage, as it provides more comprehensive overview of the tumor genomic status. Ongoing research and clinical trials suggest that exosomes and nucleosomes, will provide more efficient diagnostic results and hence market will be growing in the forecast period.

In the forecast period, continuous research and development by private manufacturers, government organizations and designated government labs along with growing number of clinical trials in liquid biopsy is anticipated to provide momentum to the market growth. However, generation of revenue from the liquid biopsy is dependent upon the interest of third party payers, hindering the market growth.

Scope of the Report

Global Liquid Biopsy Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)

Regional Liquid Biopsy Markets - North America, Europe, APAC, ROW (Actual Period: 2017-2018, Forecast Period: 2019-2024)

Country Analysis - U.S., Germany, France, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024)

Company Analysis - Roche Diagnostics, Thermo Fisher Scientific, Guardant Health, Qiagen.

Other Report Highlights

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Liquid Biopsy Market: Product Outlook

5. Global Liquid Biopsy Market: Growth and Forecast (2017-2024)

6. Global Liquid Biopsy Market: Segment Analysis

7. Global Liquid Biopsy Market: Regional Analysis

8. Global Liquid Biopsy Market: Competitive Landscape

9. Global Liquid Biopsy Market Dynamics

10. Porter's Five Forces Analysis

11. SWOT Analysis

12. Policy and Regulatory Landscape

13. Company Profiles

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기